RA Capital Management - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 127 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$130,123,836
+39.0%
5,676,0670.0%2.56%
+45.0%
Q2 2023$93,598,345
-4.9%
5,676,067
+2.9%
1.77%
-20.7%
Q1 2023$98,406,635
-38.7%
5,516,0670.0%2.23%
-31.6%
Q4 2022$160,627,871
+19.8%
5,516,067
+0.8%
3.26%
+13.9%
Q3 2022$134,041,000
+563.1%
5,471,067
+12.3%
2.86%
+430.6%
Q2 2022$20,215,000
-64.0%
4,871,0670.0%0.54%
-56.0%
Q1 2022$56,115,000
+15.4%
4,871,0670.0%1.22%
+42.8%
Q4 2021$48,613,000
-23.6%
4,871,0670.0%0.86%
-2.8%
Q3 2021$63,616,000
-10.5%
4,871,0670.0%0.88%
-22.7%
Q2 2021$71,077,000
-31.4%
4,871,0670.0%1.14%
-27.0%
Q1 2021$103,608,000
-16.6%
4,871,067
+16.6%
1.56%
-10.1%
Q4 2020$124,244,000
+11.5%
4,179,067
-18.7%
1.74%
-14.7%
Q3 2020$111,393,000
-4.1%
5,140,408
-1.3%
2.04%
-10.0%
Q2 2020$116,185,000
+40.8%
5,210,088
-3.9%
2.26%
-13.2%
Q1 2020$82,528,000
-33.7%
5,422,3120.0%2.61%
-30.9%
Q4 2019$124,496,000
+68.5%
5,422,312
+58.4%
3.78%
-14.2%
Q3 2019$73,888,000
+78.2%
3,422,312
+81.6%
4.40%
+97.8%
Q2 2019$41,465,000
-19.7%
1,884,7820.0%2.23%
-0.1%
Q1 2019$51,662,000
-1.5%
1,884,782
-3.4%
2.23%
-27.0%
Q4 2018$52,425,000
-7.9%
1,950,3320.0%3.05%
+0.4%
Q3 2018$56,891,000
+18.0%
1,950,332
+26.5%
3.04%
-2.8%
Q2 2018$48,195,0001,541,7433.13%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,075,000$47,569,3755.56%
NEA Management Company, LLC 2,909,956$66,710,7415.15%
Opaleye Management Inc. 653,000$14,970,0254.87%
Frazier Life Sciences Management, L.P. 2,371,304$54,362,1443.61%
VR Adviser, LLC 1,090,000$24,988,2502.63%
RA Capital Management 5,676,067$130,123,8362.56%
Samsara BioCapital, LLC 345,293$7,915,8422.42%
SILVERARC CAPITAL MANAGEMENT, LLC 260,537$5,972,8111.81%
Logos Global Management LP 400,000$9,170,0001.22%
Cormorant Asset Management, LP 850,000$19,486,2501.14%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders